Key Highlights

  • Change Agents Corporation officially rebrands from Avalon GloboCare Corp. reflecting a strategic shift to agentic AI software platforms.
  • The company’s common stock will trade on Nasdaq under the new ticker CHGA starting 22 July 2026, with no impact on shareholder equity.
  • Two AI SaaS platforms, Beacon (AI search optimization) and Catch-Up (autonomous content creation), anchor the company’s growth strategy.
  • The rebrand includes a corporate name reservation filed with Delaware for $75.00, expiring 13 August 2026.

Change Agents Corporation has completed its transformation from a diversified biotech player into a pure-play agentic AI software company, marking the shift with a corporate rebrand and a Nasdaq relaunch under the ticker CHGA. The move, effective 20 July 2026, reflects a strategic pivot toward subscription-based AI platforms designed to automate content creation and optimize digital discoverability for businesses. Shareholders retain identical ownership stakes, with no dilution or action required, as the company prepares to debut its new identity on 22 July.

Rebrand Finalized, Nasdaq Ticker Swap Confirmed

The company filed a Certificate of Amendment with Delaware’s Secretary of State on 17 July 2026, officially changing its legal name from Avalon GloboCare Corp. to Change Agents Corporation. Trading under the new ticker CHGA begins 22 July, while the existing CUSIP number (05344R302) remains unchanged.

The rebrand also includes a name reservation for $75.00, set to expire 13 August 2026, securing the new corporate identity ahead of expanded AI software launches.

Agentic AI Platforms Drive Revenue Shift

Change Agents’ strategy centers on two AI SaaS platforms: Beacon, an AI Generative Engine Optimization tool slated for a late-Q3 2026 launch, and Catch-Up, an autonomous content creation platform in Phase 2 development. Beacon targets the growing AI search economy, helping businesses improve visibility on AI-powered recommendation engines, a market projected to disrupt traditional search traffic. Catch-Up, developed in collaboration with AWS Premier Partner Caylent, aims to democratize video content creation for podcasters and influencers, eliminating technical barriers.

The company is also evaluating AI software opportunities in defense, security, and enterprise sectors, signaling a broader push into high-growth verticals. This pivot follows the acquisition of RPM Interactive, which bolstered its agentic AI capabilities.

From Biotech to AI: A High-Stakes Bet on Recurring Revenue

The rebrand underscores a deliberate exit from biotech, where Avalon GloboCare previously operated, toward a scalable SaaS model with recurring subscription revenue. The company’s remaining non-AI asset, the KetoAir breathalyzer, a Class I FDA-registered device, now functions as a secondary revenue stream rather than a core focus. Leadership frames the shift as a response to AI’s rapid commercialization, with Director Michael Mathews emphasizing the platforms’ potential to drive "material revenue increases" for small businesses and content creators.

The timing aligns with surging investor appetite for AI software stocks, though the company’s micro-cap status (trading as ALBT until 21 July) may limit immediate institutional interest. Analysts will watch whether the SaaS model can deliver consistent cash flow, a challenge for many early-stage AI players.

Next Catalyst: Beacon Launch and AI Sector Validation

The late-Q3 2026 launch of Beacon serves as the first major test of Change Agents’ AI strategy, with investors scrutinizing adoption metrics and customer acquisition costs. The company’s ability to monetize its platforms will hinge on converting pilot users into paying subscribers, a hurdle for many AI startups. The 22 July Nasdaq debut under CHGA could attract new retail investors, though liquidity may remain constrained until the company demonstrates revenue growth.

Change Agents’ focus on niche applications, AI search optimization and content automation, could differentiate it, but execution risks remain high in a crowded sector. FAQ:.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.